Safety of argon plasma coagulation for small bowel angiodysplasia during balloon-assisted enteroscopy in patients on antithrombotic therapy: a single-centre observational cohort study [0.03%]
抗凝治疗患者的气囊辅助小肠镜下氩气 Plasma 凝血治疗小肠血管畸形的安全性：一项单中心观察队列研究
Edric Leung,Sandeep Sihag,Conor Costigan et al.
Edric Leung et al.
Objectives: Patients with small bowel angiodysplasia are frequently prescribed antithrombotic therapy. Although balloon-assisted enteroscopy (BAE) is classified as a low-risk procedure, guidelines acknowledge limited data...
A novel articaine gargle for upper endoscopy in adults: a randomized, double-blind and placebo-controlled trial [0.03%]
成人上消化道内镜用利多卡因含漱剂的研究：一项随机、双盲和安慰剂对照试验
Niklas Mattila,Mihkel Meinberg,Anne Juppo et al.
Niklas Mattila et al.
Objective: To assess whether a gargled articaine solution makes gastroscopy more tolerable for the patient. Background: Gastroscopy is ...
The short health scale for eosinophilic oesophagitis: validation and clinical applicability in 159 Danish patients [0.03%]
丹麦159例患者的短版EOSINOPHILIC EOSS验证及其临床适用性
Line Tegtmeier Sinding,Dorte Melgaard,Anne Lund Krarup
Line Tegtmeier Sinding
Background & aims: Standardised instruments are needed to assess subjective health in eosinophilic oesophagitis (EoE). This study aimed to validate the Short Health Scale (SHS) for adults with EoE by comparing it to the v...
Clinical characteristics of primary gastrointestinal lymphoma presenting with gastrointestinal bleeding [0.03%]
以消化道出血为临床表现的原发性消化道淋巴瘤的特点分析
Chun-Lin Ying,Dong-Ge Han,Lu-Gao Tian et al.
Chun-Lin Ying et al.
Background: Primary gastrointestinal lymphoma (PGIL) is the most prevalent form of extranodal lymphoma (EL), with gastrointestinal bleeding (GIB) as a severe complication. ...
Evaluation of pegylated interferon-α therapy efficacy in patients with inactive hepatitis B surface antigen carrier state [0.03%]
评估聚乙二醇干扰素-α治疗治疗乙肝表面抗原携带者（HBeAg阴性）患者的疗效分析
Haiyi Cai,Lifen Zhu,Pei Zhou et al.
Haiyi Cai et al.
Objectives: Chronic HBV infection remains a global health challenge, with many patients progressing to cirrhosis and hepatocellular carcinoma (HCC), while inactive HBsAg carriers (IHC) are considered stable but still at r...
Beyond the codes: radiological and neurosensorial nuances in the celiac-dermatitis herpetiformis spectrum [0.03%]
超越代码：无菌性肠病- dermatitis herpetiformis谱系的放射学和神经感觉特征
Hakim Rahmoune,Nada Boutrid
Hakim Rahmoune
Background: The recent cohort study by Nilsson et al. provides the first registry-based comparison of neurological and psychiatric morbidity between dermatitis herpetiformis (DH) and celiac disease (CD) without DH, reporting divergent risk ...
Therapeutic drug monitoring in inflammatory bowel disease patients switching from intravenous to subcutaneous infliximab: insights from a prospective real-world study [0.03%]
从静脉注射切换为皮下注射英夫利昔单抗的炎症性肠病患者中的血药浓度监测：一项前瞻性真实世界研究的启示
Camilla Bergsmark,Vendel A Kristensen,Maren B Sjåmo et al.
Camilla Bergsmark et al.
Background and aims: The efficacy and safety of switching from intravenous (IV) to subcutaneous (SC) infliximab (IFX) have been demonstrated across multiple studies, but data on patients treated with high IV doses remain ...
Personalised treatment in biologically naive patients with Crohn's disease: a systematic review of the last 10 years [0.03%]
克罗恩病生物制剂初治患者的个体化治疗：过去十年的系统综述
Emil Buhl,Mads Tjørnehøj Kraaer,Jens Kjeldsen et al.
Emil Buhl et al.
Background: Biological treatment has revolutionised the management of Crohn's disease (CD), however, at baseline (pre-treatment), it is not possible to predict which biologic a patient will respond the best to. ...
Radiologic predictors of early recurrence of acute cholecystitis following percutaneous cholecystostomy tube removal [0.03%]
经皮胆囊造瘘管拔除后急性胆囊炎早期复发的放射学预测指标
Ji Hoon Yu,Ah Young Lee,Jae Woo Yeon et al.
Ji Hoon Yu et al.
Background: Percutaneous cholecystostomy (PC) is commonly utilized in high-risk patients with acute cholecystitis as either a bridge to surgery or as definitive therapy. However, early recurrence following tube removal re...
Comparison of endoscopy and mobile health index for ulcerative colitis [0.03%]
内镜与移动医疗指数在溃疡性结肠炎中的对比研究
Frigg Åslagusdatter Sommervoll,Martha Maria Eide Songstad,Hilde Løland von Volkmann et al.
Frigg Åslagusdatter Sommervoll et al.
Background and aims: At Haukeland University Hospital, the Mobile Health Index for Ulcerative Colitis (MHI-UC), a patient-reported outcome measure (PROM), is used in the outpatient clinic to detect disease activity in pat...